Regeneron DRC A Double Masked Randomized, Controlled Study of the Efficacy and Safety of Intravitreal Administration of VEGF Trap-Eye in Patients with Diabetic Macular Edema Regeneron VGFT-1009 - Extension
Research Grant
Administered By
Ophthalmology
Awarded By
Regeneron Pharmaceuticals, Inc.
Start Date
April 6, 2020
End Date
October 1, 2022
Administered By
Ophthalmology
Awarded By
Regeneron Pharmaceuticals, Inc.
Start Date
April 6, 2020
End Date
October 1, 2022